Skip to main content

Table 1 Patients’ characteristics

From: Radiotherapy combined with gefitinib for patients with locally advanced non-small cell lung cancer who are unfit for surgery or concurrent chemoradiotherapy: a phase II clinical trial

Characteristics

N(%)

Sex

 Male

24 (85.7)

 Female

4 (14.3)

Age

 Median

63

 Range

42–77

Smoking index

 0

7 (25.0)

 1–400

1 (3.6)

  ≥ 400

20 (71.4)

KPS status

 70

2 (7.1)

 80

16 (57.1)

 90

9 (32.1)

 100

1 (3.6)

Weight loss within 6 months before the treatment

 0

19 (67.9)

 <5%

4 (14.3)

  ≥ 5%

5 (17.9)

T stage

 T1

1 (3.6)

 T2

10 (35.7)

 T3

9 (32.1)

 T4

8 (28.6)

N stage

 N1

3 (10.7)

 N2

9 (32.1)

 N3

16 (57.1)

Clinical stage

 IIIA

7 (25.0)

 IIIB

21 (75.0)

Histological type

•  Squamous cell carcinoma

15 (53.6)

 Adenocarcinoma

12 (42.9)

 Neuroendocrine carcinoma

1 (3.6)

Inducing chemotherapy before TRT

 Yes

17 (60.7)

 No

11 (39.3)